Biocon’s pertuzumab biosimilar receives positive chmp opinion under EMA’s tailored clinical approach JD Supra 7d Pharma Biotech
Hlb says bile duct cancer drug lirafugratinib enters full review for European approval Asia Today 08:36 Wed, 07 Oct FDA
Biocon Malaysia gets UK Mhra approval for new drug product fill-finish unit for insulins The Hindu Business Line 10:53 Fri, 25 Sep Insulin Pharma Diabetes
MetaTech AP Unveils 2027 Growth Strategy, Partners with Zheng Yang Biomedical to Build a Regenerative Medicine Supply Chain PR Newswire (Press Release) 2h
